SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Interim Management Statement

1 Aug 2012 07:00

RNS Number : 9641I
Cranswick PLC
01 August 2012
 



1 August 2012

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

First quarter interim management statement

 

Cranswick, the UK food producer, today provides an update on trading for the period from 1 April 2012 to 31 July 2012.

 

Current trading

 

The current financial year has started in line with the Board's expectations.

 

Sales for the three months to 30 June 2012 increased by 7.4 per cent to £209 million. During the period, all categories delivered robust growth and there were strong gains in sausage, bacon and continental products.

 

There were further modest increases in pig prices during the period, albeit they remain below the peak of last summer. The impact has been absorbed through increased volumes and continued operating efficiencies.

 

As announced on 2 July 2012, the Company acquired the entire issued share capital of Kingston Foods Limited ("Kingston") on 29 June 2012. Kingston is a producer of premium cooked and roasted meat products and at 27 January 2012 had gross assets of £3.7 million. The acquisition of Kingston strengthens Cranswick's cooked meat production capabilities, further diversifies its product range in a growing market and broadens the Group's customer base.

 

Financial position

 

Net debt stood at £38 million at the quarter-end, compared to £22 million at 31 March 2012. This increase reflects a seasonal uplift in working capital and cash spent on the acquisition of Kingston. Net debt was however well below the £55 million reported at the same time last year. The Group is in a sound financial position, with committed, unsecured facilities of £100 million which provide generous headroom going forward.

 

Board change

 

As announced on 21 May 2012, Bernard Hoggarth will stand down from his position as Chief Executive Officer at today's Annual General Meeting. He will continue with Cranswick in the role of Commercial Director on a part time basis. Adam Couch will succeed Bernard as Chief Executive. Adam, who has been with the business for over 20 years, was appointed to the Board in 2003 and became Chief Operating Officer in May 2011 as part of the Board's strategy for succession planning.

 

Outlook

 

With experienced management at all levels of the Group, a strong range of products, a well invested asset base and a robust financial position, the Board, whilst mindful of the continuing challenges facing the UK consumer, remains confident in the continued long term success and development of the business.

 

 

 

Enquiries:

 

CityRoad Communications +44 (0) 20 7248 8010

Paul Quade +44 (0) 7947 186 694

 

 

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie, pastry products and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2012 showed sales of £821m and profit before tax of £48.4m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement represents Cranswick's first quarter Interim Management Statement for the period from 1 April 2012 to 31 July 2012.

4. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUAVSRUSABOAR
Date   Source Headline
5th Dec 20232:25 pmRNSDirector/PDMR Shareholding
1st Dec 20231:34 pmRNSDirector/PDMR Shareholding
29th Nov 20239:18 amRNSIssue of Equity
21st Nov 20237:00 amRNSInterim Results
1st Nov 20233:21 pmRNSTotal Voting Rights
30th Oct 20239:09 amRNSHolding(s) in Company
5th Oct 202312:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:15 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:10 pmRNSTotal Voting Rights
12th Sep 20232:06 pmRNSDirector/PDMR Shareholding
12th Sep 20232:05 pmRNSDirector/PDMR Shareholding
12th Sep 20232:03 pmRNSDirector/PDMR Shareholding
12th Sep 20232:02 pmRNSDirector/PDMR Shareholding
4th Sep 202310:30 amRNSTotal Voting Rights
29th Aug 20231:58 pmRNSDirectorate Change
29th Aug 202310:56 amRNSDirector/PDMR Shareholding
1st Aug 202312:16 pmRNSTotal Voting Rights
24th Jul 20235:56 pmRNSResult of AGM
24th Jul 20237:00 amRNSFirst quarter trading statement
3rd Jul 20232:04 pmRNSTotal Voting Rights
3rd Jul 20232:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:57 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:56 pmRNSDirector/PDMR Shareholding
14th Jun 20238:21 amRNSHolding(s) in Company
5th Jun 20235:18 pmRNSTotal Voting Rights
1st Jun 20234:08 pmRNSDirector/PDMR Shareholding
23rd May 20237:01 amRNSDirector Appointment and Board Changes
23rd May 20237:00 amRNSPRELIMINARY RESULTS
2nd May 202312:56 pmRNSTotal Voting Rights
19th Apr 20232:44 pmRNSBlock listing Interim Review
19th Apr 20232:43 pmRNSBlock listing Interim Review
5th Apr 20239:00 amRNSAdditional Listing
4th Apr 20239:30 amRNSTotal Voting Rights
22nd Mar 20237:30 amRNSDirectorate Change
20th Mar 20231:38 pmRNSHolding(s) in Company
6th Feb 202310:00 amRNSTotal Voting Rights
2nd Feb 20237:00 amRNSThird quarter trading statement
23rd Jan 20239:30 amRNSAdditional Listing
18th Jan 202312:25 pmRNSTotal Voting Rights
6th Jan 202310:57 amRNSDirector/PDMR Shareholding
3rd Jan 202311:43 amRNSDirector/PDMR Shareholding
22nd Dec 202211:20 amRNSCranswick Scrip Dividend Scheme
2nd Dec 20225:47 pmRNSHolding(s) in Company
2nd Dec 20225:07 pmRNSHolding(s) in Company
29th Nov 20227:30 amRNSDirectorship
25th Nov 20221:48 pmRNSHolding(s) in Company
23rd Nov 20223:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSInterim Results
16th Nov 20223:14 pmRNSHolding(s) in Company
3rd Nov 20222:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.